Literature DB >> 16964549

Increased protein expression of matrix metalloproteinases -1, -3, and -9 and TIMP-1 in patients with gluten-sensitive enteropathy.

Bashir M Mohamed1, Conleth Feighery, Jacinta Kelly, Christian Coates, Una O'Shea, Louise Barnes, Mohamed Abuzakouk.   

Abstract

Gluten-sensitive enteropathy is characterized by small intestinal damage. The pathogenic mechanisms involved are not precisely understood. There is recent interest in the possibility that matrix metalloproteinases might play a pathogenic role. Using immunohistochemistry technique, we examined the protein expression of matrix metalloproteinases-1, -3, and -9 and the tissue inhibitor metalloproteinase-1 in duodenal biopsies from 30 patients with celiac disease and dermatitis herpetiformis. We demonstrated that the percentage of cells expressing these enzymes and their inhibitor in all patients was significantly greater than in the normal controls (P < 0.0001). This was evident even in patients with a minimal lesion but was most marked in patients with severe damage, mirroring the degree of inflammation in the small intestinal tissue. The increased expression of these enzymes and their inhibitor in the duodenal mucosa of patients with gluten-sensitive enteropathy suggests a role for these enzymes in the tissue remodeling which is a feature of these disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16964549     DOI: 10.1007/s10620-005-9038-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.

Authors:  E Louis; C Ribbens; A Godon; D Franchimont; D De Groote; N Hardy; J Boniver; J Belaiche; M Malaise
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Molecular basis of celiac disease.

Authors:  L M Sollid
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease.

Authors:  S Daum; U Bauer; H D Foss; D Schuppan; H Stein; E O Riecken; R Ullrich
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

4.  A major role for matrix metalloproteinases in T cell injury in the gut.

Authors:  S L Pender; S P Tickle; A J Docherty; D Howie; N C Wathen; T T MacDonald
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

5.  Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.

Authors:  C J Bailey; R M Hembry; A Alexander; M H Irving; M E Grant; C A Shuttleworth
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

6.  Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.

Authors:  T Kirkegaard; A Hansen; E Bruun; J Brynskov
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

7.  Matrix metalloproteinases and their inhibitors in gastric cancer.

Authors:  G I Murray; M E Duncan; E Arbuckle; W T Melvin; J E Fothergill
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 8.  Matrix metalloproteinases in immunity.

Authors:  E J Goetzl; M J Banda; D Leppert
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

9.  Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge.

Authors:  M Kontakou; R T Przemioslo; R P Sturgess; G A Limb; H J Ellis; P Day; P J Ciclitira
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

10.  Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing.

Authors:  M T Salmela; S L F Pender; M-L Karjalainen-Lindsberg; P Puolakkainen; T T Macdonald; U Saarialho-Kere
Journal:  Scand J Gastroenterol       Date:  2004-11       Impact factor: 2.423

View more
  9 in total

1.  PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.

Authors:  Maria Paola Simula; Renato Cannizzaro; Vincenzo Canzonieri; Alessandro Pavan; Stefania Maiero; Giuseppe Toffoli; Valli De Re
Journal:  Mol Med       Date:  2010-03-03       Impact factor: 6.354

2.  Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo.

Authors:  Bashir M Mohamed; Navin K Verma; Anthony M Davies; Aoife McGowan; Kieran Crosbie-Staunton; Adriele Prina-Mello; Dermot Kelleher; Catherine H Botting; Corey P Causey; Paul R Thompson; Ger Jm Pruijn; Elena R Kisin; Alexey V Tkach; Anna A Shvedova; Yuri Volkov
Journal:  Nanomedicine (Lond)       Date:  2012-05-25       Impact factor: 5.307

3.  Immunological indicators of coeliac disease activity are not altered by long-term oats challenge.

Authors:  S E J Cooper; N P Kennedy; B M Mohamed; M Abuzakouk; J Dunne; G Byrne; G McDonald; A Davies; C Edwards; J Kelly; C F Feighery
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

Review 4.  The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.

Authors:  Christopher S McAllister; Martin F Kagnoff
Journal:  Semin Immunopathol       Date:  2012-06-07       Impact factor: 9.623

5.  Altered gene expression in highly purified enterocytes from patients with active coeliac disease.

Authors:  Suzanne Bracken; Greg Byrne; Jacinta Kelly; John Jackson; Conleth Feighery
Journal:  BMC Genomics       Date:  2008-08-08       Impact factor: 3.969

Review 6.  Celiac disease and non-celiac gluten sensitivity.

Authors:  Benjamin Lebwohl; Jonas F Ludvigsson; Peter H R Green
Journal:  BMJ       Date:  2015-10-05

7.  Mycobacterium avium lysate induces matrix metalloproteinase-1 in intestinal tissue and peripheral blood: Observations from selected hospital based Zambian adults.

Authors:  Gershom Chongwe; Charles Michelo; Edford Sinkala; Violet Kayamba; Jean-Baptiste Nzayisenga; Francis Drobniewski; Paul Kelly
Journal:  Int J Infect Dis       Date:  2018-04-20       Impact factor: 3.623

8.  Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening.

Authors:  Alexandros Laios; Bashir M Mohamed; Lynn Kelly; Richard Flavin; Stephen Finn; Lynda McEvoy; Michael Gallagher; Cara Martin; Orla Sheils; Martina Ring; Anthony Davies; Margaret Lawson; Noreen Gleeson; Tom D'Arcy; Charles d'Adhemar; Lucy Norris; Ream Langhe; Feras Abu Saadeh; John J O'Leary; Sharon A O'Toole
Journal:  Int J Mol Sci       Date:  2013-01-22       Impact factor: 5.923

Review 9.  Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder.

Authors:  Margaret R Dunne; Greg Byrne; Fernando G Chirdo; Conleth Feighery
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.